NCATS Archives
Research sheds light on how RSV wards off potential vaccines
Oct. 20, 2016—Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it.
Risk factors for delirium
Sep. 13, 2016—High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered.
Nervous system’s role in hypertension
Aug. 29, 2016—Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease.
Growth hormone for Prader-Willi
Aug. 25, 2016—Children with Prader-Willi Syndrome who received growth hormone treatment had cognitive advantages compared to untreated patients.
In search of new asthma therapies
Aug. 15, 2016—A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies.
Vanderbilt establishes Recruitment Innovation Center to increase enrollment of minorities, women and older adults in clinical trials
Jul. 5, 2016—Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this.
Superior scan for tumors
Jun. 24, 2016—Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors.
Therapies to prevent preterm birth
Feb. 9, 2016—Vanderbilt researchers have developed a high-throughput assay that will aid in identifying new compounds to treat preterm labor or postpartum bleeding.
Study identifies new culprit in lung cancer development
Jan. 27, 2016—A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.
Immune response in transplantation
Dec. 16, 2015—Thirty-three percent of pediatric heart transplant patients developed antibodies against the donor heart, which can lead to rejection, a new Vanderbilt study reports.
DISSECTing cell signaling networks
Dec. 14, 2015—Vanderbilt researchers have developed a new method to study cell signaling networks at single-cell resolution.
Children, heart disease, and IQ
Nov. 16, 2015—Treatment for congenital heart disease during infancy may result in cognitive and attentional deficits during adolescence and young adulthood, Vanderbilt researchers have found.
